Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Katia Fettucciari, Alessandro Fruganti, Andrea Marchegiani, Stefano Brancorsini, Pierfrancesco Marconi & Gabrio Bassotti. (2021) Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B. Journal of Inflammation Research 14, pages 57-62.
Read now
Read now
Tanya M Monaghan, Anna M Seekatz, Benjamin H Mullish, Claudia C. E. R Moore-Gillon, Lisa F. Dawson, Ammar Ahmed, Dina Kao & Weng C Chan. (2021) Clostridioides difficile: innovations in target discovery and potential for therapeutic success. Expert Opinion on Therapeutic Targets 25:11, pages 949-963.
Read now
Read now
Marina Muñoz, Daniel Restrepo-Montoya, Nitin Kumar, Gregorio Iraola, Giovanny Herrera, Dora I. Ríos-Chaparro, Diana Díaz-Arévalo, Manuel A. Patarroyo, Trevor D. Lawley & Juan David Ramírez. (2019) Comparative genomics identifies potential virulence factors in Clostridium tertium and C. paraputrificum. Virulence 10:1, pages 657-676.
Read now
Read now
Bhagyashri D Navalkele & Teena Chopra. (2018) Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics: Targets and Therapy 12, pages 11-21.
Read now
Read now
Articles from other publishers (85)
Adriane C. Maestri, Dany Mesa, Thais M. Vasconcelos, Damaris Krul, Marinei C. Ricieri, Fabio A. Motta, Libera M. Dalla-Costa, Sonia M. Raboni & Keite S. Nogueira. (2023) Analysis of Clostridioides difficile Infection in Children with Diarrhea in Two Hospitals in Southern Brazil. Current Microbiology 80:12.
Crossref
Crossref
Mitt M. Vongphakdi, Nicholas Ah Yui & Kevin OCallaghan. (2023)
A retrospective study investigating the management, risk factors, and outcomes of patients diagnosed with
Clostridioides difficile
infection
. Journal of Pharmacy Practice and Research 53:5, pages 262-267.
Crossref
Crossref
Nuria Tubau-Juni, Josep Bassaganya-Riera, Andrew J. Leber, Sameeksha S. Alva, Ryan Baker & Raquel Hontecillas. (2023) Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation. Scientific Reports 13:1.
Crossref
Crossref
Min Xu, Ganesh-Kumar Selvaraj & Huijie Lu. (2023) Environmental sporobiota: Occurrence, dissemination, and risks. Science of The Total Environment 869, pages 161809.
Crossref
Crossref
Jeffrey K. J. Cheng & Meera Unnikrishnan. (2023) Clostridioides difficile infection: traversing host–pathogen interactions in the gut. Microbiology 169:2.
Crossref
Crossref
Vanessa Oliveira, Ana R.M. Polónia, Daniel F.R. Cleary, Yusheng M. Huang, Nicole J. de Voogd, Tina Keller-Costa, Rodrigo Costa & Newton C.M. Gomes. (2022) Assessing the genomic composition, putative ecological relevance and biotechnological potential of plasmids from sponge bacterial symbionts. Microbiological Research 265, pages 127183.
Crossref
Crossref
Andrea Colautti, Elisabetta Orecchia, Giuseppe Comi & Lucilla Iacumin. (2022) Lactobacilli, a Weapon to Counteract Pathogens through the Inhibition of Their Virulence Factors. Journal of Bacteriology 204:11.
Crossref
Crossref
Elisa Martinez, Cristina Rodriguez, Sébastien Crèvecoeur, Sarah Lebrun, Véronique Delcenserie, Bernard Taminiau & Georges Daube. (2022)
Impact of environmental conditions and gut microbiota on the
in vitro
germination and growth of
Clostridioides difficile
. FEMS Microbiology Letters 369:1.
Crossref
Crossref
Giovanny Herrera, Juan Camilo Arboleda, Juan E. Pérez-Jaramillo, Manuel Alfonso Patarroyo, Juan David Ramírez & Marina Muñoz. (2022) Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection. Microbiology Spectrum 10:5.
Crossref
Crossref
Bryan T. Gemler, Chiranjit Mukherjee, Carrie A. Howland, Danielle Huk, Zachary Shank, Lela Johnson Harbo, Omar P. Tabbaa & Craig M. Bartling. (2022) Function-based classification of hazardous biological sequences: Demonstration of a new paradigm for biohazard assessments. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Joana Darc Freitas Alves, Augusto Yamaguti, João Silva de Mendonça, Cristiano de Melo Gamba, Cibele Lefreve Fonseca, Daniela K. S. Paraskevopoulos, Alexandre Inacio de Paula, Nair Hosino, Silvia Figueiredo Costa & Thaís Guimarães. (2022) Metronidazole for Treatment of Clostridioides difficile Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality. Antibiotics 11:9, pages 1162.
Crossref
Crossref
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2022) Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective. Frontiers in Immunology 13.
Crossref
Crossref
Tanay Kaymak, Petr Hruz & Jan Hendrik Niess. (2021) Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases. The FEBS Journal 289:16, pages 4758-4772.
Crossref
Crossref
Hiroyuki Kunishima, Hiroki Ohge, Hiromichi Suzuki, Atsushi Nakamura, Kazuaki Matsumoto, Hiroshige Mikamo, Nobuaki Mori, Yoshitomo Morinaga, Katsunori Yanagihara, Yuka Yamagishi & Sadako Yoshizawa. (2022) Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. Journal of Infection and Chemotherapy 28:8, pages 1045-1083.
Crossref
Crossref
Jianwei Chen, Yaojia Lu, Yujie Du, Hong Wang & Qiang Wu. (2022) Recent development of small-molecular inhibitors against Clostridioides difficile infection. Bioorganic Chemistry 125, pages 105843.
Crossref
Crossref
Camila Fonseca Rizek, Roberta Cristina Martins, Evelyne Santana Girão, Bruno de Melo Tavares, Sania Alves dos Santos, Gessica Lorena Gamarra, Lauro Vieira Perdigão Neto, Constancia Diogo, Tatiana D' Annibale Orsi, Icaro Boszczowski, Filipe Piastrelli, Cecilia Leite Costa, Daniely Viana Costa, Geovania Maciel, Janete Romão, Gerly Anne de Castro Brito & Silvia Figueiredo Costa. (2022) Clostridioides difficile from Brazilian hospitals: characterization of virulence genes by whole genome sequencing. Microbes and Infection 24:5, pages 104953.
Crossref
Crossref
Michelle M. O’Donnell, James W. Hegarty, Brian Healy, Sarah Schulz, Calum J. Walsh, Colin Hill, R. Paul Ross, Mary C. Rea, Ronald Farquhar & Laurent Chesnel. (2022) Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities. Scientific Reports 12:1.
Crossref
Crossref
Seçil Abay, Emral Fevzi Ahmed, Fuat Aydin, Emre Karakaya & Hamit Kaan Müştak. (2022) Presence of Clostridioides difficile in cattle feces, carcasses, and slaughterhouses: Molecular characterization and antibacterial susceptibility of the recovered isolates. Anaerobe 75, pages 102575.
Crossref
Crossref
Salud Rodríguez-Pallares, Pablo Fernández-Palacios, Estefanía Jurado-Tarifa, Federico Arroyo, Manuel A. Rodríguez-Iglesias & Fátima Galán-Sánchez. (2022) Transmission of toxigenic Clostridiodes difficile between a pet dog with diarrhea and a 10-month-old infant. Anaerobe 74, pages 102519.
Crossref
Crossref
Mohd Baasir Gaisawat, Silvia Lopez-Escalera, Chad W. MacPherson, Michèle M. Iskandar, Thomas A. Tompkins & Stan Kubow. (2022) Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water. Frontiers in Microbiology 12.
Crossref
Crossref
Jennifer Moisi. (2022) Clostridioides difficile-Infection (CDI). VacciTUTOR.
Crossref
Crossref
Eliane de Oliveira Ferreira & Gerly Anne de Castro Brito. 2022. Molecular Typing in Bacterial Infections, Volume II. Molecular Typing in Bacterial Infections, Volume II
19
33
.
Mackingsley Kushan Dassanayake, Teng-Jin Khoo & Jia An. (2021) Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Crossref
Liyou Dong, Monic M. Tomassen, Renata M. C. Ariëns, Els Oosterink, Harry J. Wichers, Teun Veldkamp, Jurriaan J. Mes & Coen Govers. (2021)
Clostridioides difficile
toxin A-mediated Caco-2 cell barrier damage was attenuated by insect-derived fractions and corresponded to increased gene transcription of cell junctional and proliferation proteins
. Food & Function 12:19, pages 9248-9260.
Crossref
Crossref
Po-Jung Chiu, Jagat Rathod, Yu-Ping Hong, Pei-Jane Tsai, Yuan-Pin Hung, Wen-Chien Ko, Jenn-Wei Chen, Daniel Paredes-Sabja & I-Hsiu Huang. (2021) Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages. Anaerobe 70, pages 102381.
Crossref
Crossref
Dvison de Melo Pacífico, Cecília Leite Costa, Hercules Moura, John R. Barr, Guilherme Augusto Maia, Vilmar Benetti Filho, Renato Simões Moreira, Glauber Wagner, Regina Maria Cavalcanti Pilotto Domingues, Carlos Quesada-Gómez, Eliane de Oliveira Ferreira & Gerly Anne de Castro Brito. (2021) Exoproteomic analysis of two MLST clade 2 strains of Clostridioides difficile from Latin America reveal close similarities. Scientific Reports 11:1.
Crossref
Crossref
Marc Landenberger, Julian Nieland, Maurice Roeder, Katharina Nørgaard, Panagiotis Papatheodorou, Katharina Ernst & Holger Barth. (2021) The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb. Biochimica et Biophysica Acta (BBA) - Biomembranes 1863:6, pages 183603.
Crossref
Crossref
Adriana Badilla-Lobo & César Rodríguez. (2021) Microbiological features, epidemiology, and clinical presentation of Clostridioides difficile strains from MLST Clade 2: A narrative review. Anaerobe 69, pages 102355.
Crossref
Crossref
Marco Terreni, Marina Taccani & Massimo Pregnolato. (2021) New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Molecules 26:9, pages 2671.
Crossref
Crossref
Sathursha Gunaratnam, Mathieu Millette, Lynne V. McFarland, Herbert L. DuPont & Monique Lacroix. (2021) Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems. Microbial Pathogenesis 153, pages 104798.
Crossref
Crossref
Takashi Okanda, Hiroshi Mitsutake, Ryoko Aso, Ryuichi Sekizawa, Hiromu Takemura, Tetsuya Matsumoto & Shigeki Nakamura. (2021) Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device. Diagnostic Microbiology and Infectious Disease 99:2, pages 115247.
Crossref
Crossref
Zhenrui Pan, Yuanyuan Zhang, Jianhua Luo, Danyang Li, Yao Zhou, Liuqing He, Qi Yang, Min Dong & Liang Tao. (2021) Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology. PLOS Pathogens 17:1, pages e1009197.
Crossref
Crossref
Kanika Sehgal & Sahil Khanna. (2021)
Immune response against
Clostridioides difficile
and translation to therapy
. Therapeutic Advances in Gastroenterology 14, pages 175628482110148.
Crossref
Crossref
Babita Adhikari Dhungel & Revathi Govind. (2020)
Spo0A Suppresses
sin
Locus Expression in Clostridioides difficile
. mSphere 5:6.
Crossref
Crossref
George A. Naclerio, Nader S. Abutaleb, Daoyi Li, Mohamed N. Seleem & Herman O. Sintim. (2020)
Ultrapotent Inhibitor of
Clostridioides difficile
Growth, Which Suppresses Recurrence
In Vivo
. Journal of Medicinal Chemistry 63:20, pages 11934-11944.
Crossref
Crossref
Urvashi, Stanzin Choksket, Ashish Jain, Deepika Sharma, Vishakha Grover & Suresh Korpole. (2020) Paraclostridium dentum, a novel species with pathogenic features isolated from human dental plaque sample. Anaerobe 65, pages 102239.
Crossref
Crossref
Matthew L. Jenior & Jason A. Papin. (2020) Clostridioides difficile: Sometimes It Pays To Be Difficult. Cell Host & Microbe 28:3, pages 358-359.
Crossref
Crossref
Gabrio Bassotti, Andrea Marchegiani, Pierfrancesco Marconi & Katia Fettucciari. (2020)
The cytotoxic synergy between
Clostridioides difficile
toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of
Clostridioides difficile
infection and relapses
. MicrobiologyOpen 9:8.
Crossref
Crossref
Yu Chen, Kai Huang, Liang-Kuei Chen, Hui-Yu Wu, Chih-Yu Hsu, Yau-Sheng Tsai, Wen-Chien Ko & Pei-Jane Tsai. (2020) Membrane Cholesterol Is Crucial for Clostridium difficile Surface Layer Protein Binding and Triggering Inflammasome Activation. Frontiers in Immunology 11.
Crossref
Crossref
Krzysztof Skowron, Katarzyna Grudlewska-Buda, Sylwia Kożuszko, Natalia Wiktorczyk, Karolina Jadwiga Skowron, Agnieszka Mikucka, Zuzanna Bernaciak & Eugenia Gospodarek-Komkowska. (2020) Efficacy of Radiant Catalytic Ionization in Reduction of Enterococcus spp., Clostridioides difficile and Staphylococcus aureus in Indoor Air. Atmosphere 11:7, pages 764.
Crossref
Crossref
Nader S. Abutaleb & Mohamed N. Seleem. (2020) Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Scientific Reports 10:1.
Crossref
Crossref
Rusha Pal & Mohamed N. Seleem. (2020) Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile. Scientific Reports 10:1.
Crossref
Crossref
Nicole A Loeven, Natasha P Medici & James B. Bliska. (2020) The pyrin inflammasome in host–microbe interactions. Current Opinion in Microbiology 54, pages 77-86.
Crossref
Crossref
Mohd Baasir Gaisawat, Chad W. MacPherson, Julien Tremblay, Amanda Piano, Michèle M. Iskandar, Thomas A. Tompkins & Stan Kubow. (2019) Probiotic Supplementation in a Clostridium difficile-Infected Gastrointestinal Model Is Associated with Restoring Metabolic Function of Microbiota. Microorganisms 8:1, pages 60.
Crossref
Crossref
Laura Tijerina-Rodríguez, Licet Villarreal-Treviño, Rayo Morfín-Otero, Adrián Camacho-Ortíz & E. Garza-González. (2019)
Virulence Factors of
Clostridioides
(
Clostridium
)
difficile
Linked to Recurrent Infections
. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-7.
Crossref
Crossref
Mahmoud M. Saleh & William A. PetriJr.Jr.. (2019) Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?. Infection and Immunity 88:1.
Crossref
Crossref
Eric Krueger & Angela C. Brown. (2019) Inhibition of bacterial toxin recognition of membrane components as an anti-virulence strategy. Journal of Biological Engineering 13:1.
Crossref
Crossref
Melanie L Hutton, Havva Pehlivanoglu, Callum J Vidor, Meagan L James, Melanie J Thomson & Dena Lyras. (2019) Repurposing auranofin as a Clostridioides difficile therapeutic. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Sarah A. Revitt-Mills, Callum J. Vidor, Thomas D. Watts, Dena Lyras, Julian I. Rood & Vicki Adams. 2019. Gram-Positive Pathogens. Gram-Positive Pathogens
954
976
.
Yusuf Ciftci, Brintha Parasumanna Girinathan, Babita Adhikari Dhungel, Md Kamrul Hasan & Revathi Govind. (2019) Clostridioides difficile SinR’ regulates toxin, sporulation and motility through protein-protein interaction with SinR. Anaerobe 59, pages 1-7.
Crossref
Crossref
Marina Muñoz, Daniel Restrepo-Montoya, Nitin Kumar, Gregorio Iraola, Milena Camargo, Diana Díaz-Arévalo, Nelly S. Roa-Molina, Mayra A. Tellez, Giovanny Herrera, Dora I. Ríos-Chaparro, Claudia Birchenall, Darío Pinilla, Juan M. Pardo-Oviedo, Giovanni Rodríguez-Leguizamón, Diego F. Josa, Trevor D. Lawley, Manuel A. Patarroyo & Juan David Ramírez. (2019) Integrated genomic epidemiology and phenotypic profiling of Clostridium difficile across intra-hospital and community populations in Colombia. Scientific Reports 9:1.
Crossref
Crossref
Dimitrios K. Matthaiou, Dimitra Delga, Maria Daganou, Antonia Koutsoukou, Niki Karabela, Konstantinos E. Mandragos, Eleni Kalogeropoulou & George Dimopoulos. (2019) Characteristics, risk factors and outcomes of Clostridium difficile infections in Greek Intensive Care Units. Intensive and Critical Care Nursing 53, pages 73-78.
Crossref
Crossref
K. Rainha, R. Fernandes Ferreira, C.N.R. Trindade, L.G. Carneiro, B. Penna, B.T. Endres, K. Begum, M.J. Alam, K.W. Garey, C.P. Domingues Regina Maria & E.O. Ferreira. (2019) Characterization of Clostridioides difficile ribotypes in domestic dogs in Rio de Janeiro, Brazil. Anaerobe 58, pages 22-29.
Crossref
Crossref
C.N.R. Trindade, Regina Maria C.P. Domingues & E.O. Ferreira. (2019) The epidemiology of Clostridioides difficile infection in Brazil: A systematic review covering thirty years. Anaerobe 58, pages 13-21.
Crossref
Crossref
Sarah A. Revitt-Mills, Callum J. Vidor, Thomas D. Watts, Dena Lyras, Julian I. Rood & Vicki Adams. (2019) Virulence Plasmids of the Pathogenic Clostridia. Microbiology Spectrum 7:3.
Crossref
Crossref
Reece J. Knippel, Joseph P. Zackular, Jessica L. Moore, Arianna I. Celis, Andy Weiss, M. Kay Washington, Jennifer L. DuBois, Richard M. Caprioli & Eric P. Skaar. (2018) Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection. PLOS Pathogens 14:12, pages e1007486.
Crossref
Crossref
Amber Howerton, Cale O. Seymour, Senthil K. Murugapiran, Zhenlin Liao, Jacqueline R. Phan, Alan Estrada, Adam J. Wagner, Chrisabelle C. Mefferd, Brian P. Hedlund & Ernesto Abel-Santos. (2018) Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Francisco A. Uzal, Mauricio A. Navarro, Jihong Li, John C. Freedman, Archana Shrestha & Bruce A. McClane. (2018) Comparative pathogenesis of enteric clostridial infections in humans and animals. Anaerobe 53, pages 11-20.
Crossref
Crossref
Michael Samarkos, Elpida Mastrogianni & Olga Kampouropoulou. (2018) The role of gut microbiota in Clostridium difficile infection. European Journal of Internal Medicine 50, pages 28-32.
Crossref
Crossref
Jacob Amy, Dieter Bulach, Daniel Knight, Tom Riley, Priscilla Johanesen & Dena Lyras. (2018) Identification of large cryptic plasmids in Clostridioides (Clostridium) difficile. Plasmid 96-97, pages 25-38.
Crossref
Crossref
Huawei Gu, Yingyin Yang, Meng Wang, Shuyi Chen, Haiying Wang, Shan Li, Yi Ma & Jufang Wang. (2018) Novel Cysteine Desulfidase CdsB Involved in Releasing Cysteine Repression of Toxin Synthesis in Clostridium difficile. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Molly Flanagan & Paula Ferrada. 2018. Geriatric Trauma and Acute Care Surgery. Geriatric Trauma and Acute Care Surgery
291
297
.
Cherisse L. Hall & Vincent T. Lee. (2017) Cyclic‐di‐GMP regulation of virulence in bacterial pathogens. WIREs RNA 9:1.
Crossref
Crossref
Marina Muñoz, Dora Inés Ríos-Chaparro, Manuel Alfonso Patarroyo & Juan David Ramírez. (2017) Determining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases. BMC Microbiology 17:1.
Crossref
Crossref
Ramyavardhanee Chandrasekaran & D. Borden Lacy. (2017) The role of toxins in Clostridium difficile infection. FEMS Microbiology Reviews 41:6, pages 723-750.
Crossref
Crossref
Raymond Kiu, Shabhonam Caim, Cristina Alcon-Giner, Gusztav Belteki, Paul Clarke, Derek Pickard, Gordon Dougan & Lindsay J. Hall. (2017) Preterm Infant-Associated Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum Strains: Genomic and Evolutionary Insights. Genome Biology and Evolution 9:10, pages 2707-2714.
Crossref
Crossref
Ebrahim Rezazadeh Zarandi, Shahla Mansouri, Nouzar Nakhaee, Farhad Sarafzadeh & Mohammad Moradi. (2017) Effect of sub-MIC of vancomycin and clindamycin alone and in combination with ceftazidime on Clostridium difficile surface layer protein A (slpA) gene expression. Microbial Pathogenesis 111, pages 163-167.
Crossref
Crossref
Joana Isidro, Aristides L. Mendes, Mónica Serrano, Adriano O. Henriques & Mónica Oleastro. 2017. Clostridium Difficile - A Comprehensive Overview. Clostridium Difficile - A Comprehensive Overview.
Yi-Wen Liu, Yu-Hung Chen, Jenn-Wei Chen, Pei-Jane Tsai & I-Hsiu Huang. (2017) Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model. Frontiers in Microbiology 8.
Crossref
Crossref
Jing-Hui Tian, Gregory Glenn, David Flyer, Bin Zhou, Ye Liu, Eddie Sullivan, Hua Wu, James F. Cummings, Larry Elllingsworth & Gale Smith. (2017) Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Vaccine 35:33, pages 4079-4087.
Crossref
Crossref
Melanie L. Hutton, Bliss A. Cunningham, Kate E. Mackin, Shelley A. Lyon, Meagan L. James, Julian I. Rood & Dena Lyras. (2017) Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative. Scientific Reports 7:1.
Crossref
Crossref
Pingping Xing, Yanan Shi, Chuangchuang Dong, Hong Liu, Yan Cheng, Junbo Sun, Dalei Li, Min Li, Kaoxiang Sun & Dongxiao Feng. (2016) Colon-Targeted Delivery of IgY Against Clostridium difficile Toxin A and B by Encapsulation in Chitosan-Ca Pectinate Microbeads. AAPS PharmSciTech 18:4, pages 1095-1103.
Crossref
Crossref
Ira Ekmekciu, Eliane von Klitzing, Ulrike Fiebiger, Ulrike Escher, Christian Neumann, Petra Bacher, Alexander Scheffold, Anja A. Kühl, Stefan Bereswill & Markus M. Heimesaat. (2017) Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Frontiers in Immunology 8.
Crossref
Crossref
Briony Elliott, Grace O. Androga, Daniel R. Knight & Thomas V. Riley. (2017) Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology. Infection, Genetics and Evolution 49, pages 1-11.
Crossref
Crossref
Jieun Kim, Yeonjae Kim & Hyunjoo Pai. (2016) Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains. PLOS ONE 11:12, pages e0168849.
Crossref
Crossref
Michael C. Abt, Peter T. McKenney & Eric G. Pamer. (2016) Clostridium difficile colitis: pathogenesis and host defence. Nature Reviews Microbiology 14:10, pages 609-620.
Crossref
Crossref
Shelley A. Lyon, Melanie L. Hutton, Julian I. Rood, Jackie K. Cheung & Dena Lyras. (2016) CdtR Regulates TcdA and TcdB Production in Clostridium difficile. PLOS Pathogens 12:7, pages e1005758.
Crossref
Crossref
Imad Kansau, Amira Barketi-Klai, Marc Monot, Sandra Hoys, Bruno Dupuy, Claire Janoir & Anne Collignon. (2016) Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis. PLOS ONE 11:6, pages e0158204.
Crossref
Crossref
Wiep Klaas Smits, Dena Lyras, D. Borden Lacy, Mark H. Wilcox & Ed J. Kuijper. (2016) Clostridium difficile infection. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Jessica S. H. Martin, Tanya M. Monaghan & Mark H. Wilcox. (2016) Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nature Reviews Gastroenterology & Hepatology 13:4, pages 206-216.
Crossref
Crossref
Bradley G. Stiles. 2017. Uptake and Trafficking of Protein Toxins. Uptake and Trafficking of Protein Toxins
135
162
.
Priscilla Johanesen, Kate Mackin, Melanie Hutton, Milena Awad, Sarah Larcombe, Jacob Amy & Dena Lyras. (2015) Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance. Genes 6:4, pages 1347-1360.
Crossref
Crossref
Joseph M. Sturino, Karina Pokusaeva & Robert Carpenter. (2015) Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate. Antimicrobial Agents and Chemotherapy 59:12, pages 7178-7183.
Crossref
Crossref
Jacob Amy, Priscilla Johanesen & Dena Lyras. (2015) Extrachromosomal and integrated genetic elements in Clostridium difficile. Plasmid 80, pages 97-110.
Crossref
Crossref
Kate E Mackin & Dena Lyras. (2015) The complex factors that contribute to Clostridium difficile infection. Microbiology Australia 36:3, pages 104.
Crossref
Crossref